BioWorld MedTech

June 2, 2010

Deals roundup: Covidien to pay $2.6 billion for ev3, sell sleep business

In an effort to boost its presence in the vascular market, Covidien (Dublin, Ireland) said Tuesday it would buy ev3 (Plymouth, Minnesota) for $22.50 a share in cash, or $2.6 billion. (Medical Device Daily) Read More

St. Jude Medical reinvigorates its cardiovascular business

Washington roundup: FDA again claims authority over drugs-of-abuse test kits

International report: Elekta acquires Resonant Medical for $30M in cash

Financings roundup: National Health Investors in $20M funding accord with CFG

MDD's food for med tech thought

Agreements/contracts: Naples Diagnostic to use IntelePACS mammography

Court report: Applied gets settlement against false advertising

Med-Tech Notes

Product Briefs

People in the News

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for March 27, 2026.

Illustration of Alzheimer's disease in the brain

ADPD 2026: Three inflection points to target Alzheimer’s disease

BioWorld Science

A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...

Emerging therapeutic strategies for Parkinson’s at ADPD 2026

BioWorld

Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...

News in brief

BioWorld Asia

BioWorld Asia briefs for March 24, 2026

SERCA inhibitor shows promise for MSA-C treatment

BioWorld Science

At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, researchers...